Stonepine Capital Management »

Okyo Pharma shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Okyo Pharma (OKYO) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Okyo Pharma

Tip: Access up to 7 years of quarterly data

All positions including Okyo Pharma held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Okyo Pharma by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 850k 1.61

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Okyo Pharma

Woodline Partners
Maven Securities
Stonepine Capital Management
Balyasny Asset Management
UBS Group
XTX Topco
HPM Partners
Geode Capital Management
Dauntless Investment Group
EFG International
Advisor Group Holdings
Morgan Stanley

View all funds holding Okyo Pharma